Document is current
Any future updates will be listed below
-
Authors
Anderle, Nicole
Schäfer-Ruoff, Felix
Staebler, Annette
Kersten, Nicolas
Koch, André
Önder, Cansu
Keller, Anna-Lena
Liebscher, Simone
Hartkopf, Andreas
Hahn, Markus
Templin, Markus
Brucker, Sara Y.
Schenke-Layland, Katja
Schmees, Christian https://orcid.org/0000-0003-4883-2642
-
Funding
Funding for this research was provided by:
Ministerium für Wirtschaft, Arbeit und Wohnungsbau Baden-Württemberg (3-4332.62-HSG/84)
- License Information
-
More Information
Article History
Received: 6 April 2023
Accepted: 28 July 2023
First Online: 18 August 2023
Declarations
:
: The use of human samples was approved by the local Ethics Commission at the Medical Faculty Tuebingen under the reference number 788/2018BO2 (15 November 2018). All patients enrolled gave their informed consent to participate in the study prior to surgery.
: A.H. received consulting and speaking fees from AstraZeneca, Amgen, Clovis, Daichii Synkyo, Eisai, ExactScience, Gilead, GSK, Hexal, Lilly, MSD, Novartis, Pfizer, Roche, Pierre-Fabre and Seagen. N.A., F.S-R., N.K, A.K., A.-L.K., B.G., A.S., S.L., M.P., M.H., S.Y.B., K.S-L., M.T. and C.S. declare no competing interest.
